Hesler B D, Dalton J E, Singh H, Chahar P, Saager L, Sessler D I, Turan A
Department of Outcomes Research
Department of Outcomes Research Department of Quantitative Health Sciences.
Br J Anaesth. 2014 Nov;113(5):792-9. doi: 10.1093/bja/aeu164. Epub 2014 Jun 25.
Fibromyalgia, the classic non-inflammatory pain syndrome, has been associated with chronic inflammatory makers which are linked with increased morbidity and mortality. We tested the primary hypothesis that patients with fibromyalgia undergoing hospital procedures have a high risk of cardiovascular complications. Our secondary goals were to evaluate the association of fibromyalgia with: (i) in-hospital thromboembolic events, (ii) in-hospital mortality, and (iii) in-hospital microvascular complications.
We obtained 21.78 million discharge records from 2009 to 2010 from the US Agency for Healthcare Research and Quality censuses across the seven states. We matched fibromyalgia records and compared records with controls based on age, gender, state of discharge, principal procedure, and a propensity score developed from the set of diagnosis-related predictors. A multivariable logistic regression was used to compare matched fibromyalgia patients and controls on the primary and secondary outcomes.
We matched 89 589 pairs for a total sample size of 179 178 discharge records. The adjusted odds ratio for in-hospital cardiovascular complications was 1.04 [99% confidence interval (CI): 0.90-1.19, P=0.51], for thromboembolic events was 1.03 (99% CI: 0.93-1.15, P=0.46), for in-hospital mortality was 0.81 (99% CI: 0.73-0.89, P<0.001), and for microvascular complications was 0.96 (99% CI: 0.88, 1.04, P=0.18). Two separate sensitivity analyses produced results similar to that of the primary analysis for all three complication outcomes.
We found no evidence that the diagnosis of fibromyalgia increased the risk of in-hospital complications. Fibromyalgia seems to be associated with a reduction in in-hospital mortality, but this requires confirmation with a large prospective controlled study.
纤维肌痛是典型的非炎性疼痛综合征,与慢性炎症标志物有关,而这些标志物与发病率和死亡率的增加相关。我们检验了主要假设,即接受医院手术的纤维肌痛患者发生心血管并发症的风险很高。我们的次要目标是评估纤维肌痛与以下因素的关联:(i)院内血栓栓塞事件,(ii)院内死亡率,以及(iii)院内微血管并发症。
我们从美国医疗保健研究与质量局对七个州2009年至2010年的普查中获取了2178万份出院记录。我们对纤维肌痛记录进行匹配,并根据年龄、性别、出院州、主要手术以及从一组诊断相关预测因素得出的倾向评分,将记录与对照组进行比较。使用多变量逻辑回归来比较匹配的纤维肌痛患者和对照组在主要和次要结局方面的情况。
我们匹配了89589对,总样本量为179178份出院记录。院内心血管并发症的调整优势比为1.04 [99%置信区间(CI):0.90 - 1.19,P = 0.51],血栓栓塞事件为1.03(99% CI:0.93 - 1.15,P = 0.46),院内死亡率为0.81(99% CI:0.73 - 0.89,P < 0.001),微血管并发症为0.96(99% CI:0.88,1.04,P = 0.18)。两项单独的敏感性分析得出的结果与所有三种并发症结局的主要分析结果相似。
我们没有发现证据表明纤维肌痛的诊断会增加院内并发症的风险。纤维肌痛似乎与院内死亡率的降低有关,但这需要通过大型前瞻性对照研究来证实。